1.    PRODUCT OVERVIEW

1.1.  MARKET DEFINITION

1.2.  SCOPE OF THE MARKET

1.2.1.    MARKETS COVERED

1.2.2.    YEARS CONSIDERED FOR STUDY

1.2.3.    KEY MARKET SEGMENTATIONS

2.    RESEARCH METHODOLOGY

2.1.  OBJECTIVE OF THE STUDY

2.2.  BASELINE METHODOLOGY

2.3.  KEY INDUSTRY PARTNERS

2.4.  MAJOR ASSOCIATION AND SECONDARY SOURCES

2.5.  FORECASTING METHODOLOGY

2.6.  DATA TRIANGULATION & VALIDATION

2.7.  ASSUMPTIONS AND LIMITATIONS

3.    EXECUTIVE SUMMARY

3.1.  OVERVIEW OF THE MARKET

3.2.  OVERVIEW OF KEY MARKET SEGMENTATIONS

3.3.  OVERVIEW OF KEY MARKET PLAYERS

3.4.  OVERVIEW OF KEY REGIONS/COUNTRIES

3.5.  OVERVIEW OF MARKET DRIVERS, CHALLENGES, TRENDS

4.    VOICE OF CUSTOMER

5.     JAPAN ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET OUTLOOK

5.1.  MARKET SIZE & FORECAST

5.1.1.    BY VALUE

5.2.  MARKET SHARE & FORECAST

5.2.1.    BY COMPONENT (SOFTWARE, HARDWARE, SERVICES)

5.2.2.    BY DIAGNOSIS TYPE (CARDIOLOGY, ONCOLOGY, PATHOLOGY, RADIOLOGY, CHEST AND LUNG, NEUROLOGY, OTHERS)

5.2.3.    BY REGION

5.2.4.    BY COMPANY (2024)

5.3.  MARKET MAP

6.    HOKKAIDO ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET OUTLOOK

6.1.  MARKET SIZE & FORECAST

6.1.1.    BY VALUE

6.2.  MARKET SHARE & FORECAST

6.2.1.    BY COMPONENT

6.2.2.    BY DIAGNOSIS TYPE

7.    TOHOKU ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET OUTLOOK

7.1.  MARKET SIZE & FORECAST

7.1.1.    BY VALUE

7.2.  MARKET SHARE & FORECAST

7.2.1.    BY COMPONENT

7.2.2.    BY DIAGNOSIS TYPE

8.    KANTO ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET OUTLOOK

8.1.  MARKET SIZE & FORECAST

8.1.1.    BY VALUE

8.2.  MARKET SHARE & FORECAST

8.2.1.    BY COMPONENT

8.2.2.    BY DIAGNOSIS TYPE

9.    CHUBU ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET OUTLOOK

9.1.  MARKET SIZE & FORECAST

9.1.1.    BY VALUE

9.2.  MARKET SHARE & FORECAST

9.2.1.    BY COMPONENT

9.2.2.    BY DIAGNOSIS TYPE

10. KANSAI ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET OUTLOOK

10.1.   MARKET SIZE & FORECAST        

10.1.1. BY VALUE

10.2.   MARKET SHARE & FORECAST

10.2.1. BY COMPONENT

10.2.2. BY DIAGNOSIS TYPE

11. CHUGOKU ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET OUTLOOK

11.1.   MARKET SIZE & FORECAST        

11.1.1. BY VALUE

11.2.   MARKET SHARE & FORECAST

11.2.1. BY COMPONENT

11.2.2. BY DIAGNOSIS TYPE

12. SHIKOKU ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET OUTLOOK

12.1.   MARKET SIZE & FORECAST        

12.1.1. BY VALUE

12.2.   MARKET SHARE & FORECAST

12.2.1. BY COMPONENT

12.2.2. BY DIAGNOSIS TYPE

13. KYUSHU ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET OUTLOOK

13.1.   MARKET SIZE & FORECAST        

13.1.1. BY VALUE

13.2.   MARKET SHARE & FORECAST

13.2.1. BY COMPONENT

13.2.2. BY DIAGNOSIS TYPE

14. MARKET DYNAMICS

14.1.   DRIVERS

14.2.   CHALLENGES

15. MARKET TRENDS & DEVELOPMENTS

15.1.   RECENT DEVELOPMENTS

15.2.   PRODUCT LAUNCHES

15.3.   MERGERS & ACQUISITIONS

16.  JAPAN ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSTICS MARKET: SWOT ANALYSIS

17. COMPETITIVE LANDSCAPE

17.1.   FUJIFILM HOLDINGS CORPORATION

17.1.1.       BUSINESS OVERVIEW

17.1.2.       PRODUCT & SERVICE OFFERINGS

17.1.3.       RECENT DEVELOPMENTS

17.1.4.       FINANCIALS (IF LISTED)

17.1.5.       KEY PERSONNEL

17.1.6.       SWOT ANALYSIS

17.2.   TOSHIBA CORPORATION

17.3.   SIEMENS HEALTHINEERS AG

17.4.   KONINKLIJKE PHILIPS N.V.

17.5.   GE HEALTHCARE TECHNOLOGIES INC

17.6.   GOOGLE HEALTH

17.7.   NEC CORPORATION

17.8.   SYSMEX CORPORATION

17.9.   AI MEDICAL SERVICE INC.

17.10.MEDMAIN INC.

18. STRATEGIC RECOMMENDATIONS

19. ABOUT US & DISCLAIMER